Ospedale SS. Annunziata

Running trials

• Recruiting

  An Efficacy and Safety Study of DFL24498 in the Treatment of AKC

  NCT07395232· Phase 3· Dompé Farmaceutici S.p.A· Source

• Active, not recruiting

  REal-life ON PARKinson's - ITaly (REONPARK-IT)

  NCT07403799· Bial - Portela C S.A.· Source

• Not yet recruiting

  Point-of-care Low-field MRI in Acute Stroke

  NCT05816213· University of L'Aquila· Source

• Recruiting

  DESTINY Breast Respond HER2-(Ultra)Low Europe

  NCT05945732· Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company· Source

• Recruiting

  Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

  NCT04662723· Phase 4· Fondazione Schena· Source

• Recruiting

  Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.

  NCT03994471· Phase 3· Iperboreal Pharma Srl· Source

• Recruiting

  Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)

  NCT04996017· Phase 3· Gruppo Oncologico Italiano di Ricerca Clinica· Source

• Recruiting

  FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

  NCT04625907· Phase 1/2· University of Birmingham· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Chronic kidney disease1 recruiting
• IgA nephropathy1 recruiting
• Lung cancer1 recruiting
• Mesothelioma1 recruiting
• Sarcoma1 recruiting
• Stroke1 recruiting

Closed trials

• Completed

  A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid Arthritis

  NCT04497597· AbbVie· Source

• Terminated

  A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension

  NCT04271475· Phase 3· Actelion· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Psoriatic arthritis11 works · 0 trials